HOXB5 and neoplasm: In vivo tumorigenicity assays illustrated that HOXB5 upregulation increased tumor growth of PLC/PRF/5 cells, whereas HOXB5 knockdown impaired tumor growth of MHCC97H cells (Figure S2C-D).